Cowden Support Program Review' title='Cowden Support Program Review' />Promote the habit of Hand Washing with Soap and Water to decrease episodes of diarrhoea. To ensure the sufficient availability of soap, partnerships with local. The above policy is based on the following references Centers for Disease Control and Prevention. Maganic Wars Pc. Update National Breast and Cervical Cancer Early Detection Program. Original Article. A Phase 3 Trial of RTS,SAS01 Malaria Vaccine in African Infants. The RTS,S Clinical Trials Partnership. N Engl J Med 2012 36722842295 December. Cowden+Support+Program.jpg' alt='Cowden Support Program Review' title='Cowden Support Program Review' />Surgery to Reduce the Risk of Breast Cancer Fact Sheet. Guillem JG, Wood WC, Moley JF, et al. ASCOSSO review of current role of risk reducing surgery in common hereditary cancer syndromes. Journal of Clinical Oncology 2. Pub. Med AbstractHartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. Number 0105. Policy. Aetna considers magnetic resonance imaging MRI, with or without contrast materials, of the breast medically necessary for members who have had. New England Journal of Medicine 1. Pub. Med AbstractDomchek SM, Friebel TM, Singer CF, et al. Association of risk reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2. 01. 0 3. Pub. Med AbstractRebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers The PROSE Study Group. Journal of Clinical Oncology 2. Cowden Support Program Review' title='Cowden Support Program Review' />Pub. Med AbstractMeijers Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. New England Journal of Medicine 2. Pub. Med AbstractChen S, Parmigiani G. Meta analysis of BRCA1 and BRCA2 penetrance. Journal of Clinical Oncology 2. Pub. Med AbstractAntoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history A combined analysis of 2. American Journal of Human Genetics 2. Pub. Med AbstractBennett KL, Mester J, Eng C. Germline epigenetic regulation of KILLIN in Cowden and Cowden like syndrome. JAMA 2. 01. 0 3. Pub. Med AbstractHobert JA, Eng C. PTEN hamartoma tumor syndrome An overview. Genetics in Medicine 2. Pub. Med AbstractTan MH, Mester JL, Ngeow J, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clinical Cancer Research 2. Pub. Med AbstractMasciari S, Dillon DA, Rath M, et al. Breast cancer phenotype in women with TP5. A Li Fraumeni syndrome consortium effort. Breast Cancer Research and Treatment 2. Pub. Med AbstractDe Bruin ML, Sparidans J, vant Veer MB, et al. Breast cancer risk in female survivors of Hodgkins lymphoma Lower risk after smaller radiation volumes. Journal of Clinical Oncology 2. Pub. Med AbstractLostumbo L, Carbine NE, Wallace J. Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database of Systematic Revviews 2. Cd. 00. 27. 48. Pub. Med AbstractKing TA, Sakr R, Patil S, et al. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy. Journal of Clinical Oncology 2. Pub. Med AbstractCuzick J, Sestak I, Baum M, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early stage breast cancer 1. ATAC trial. Lancet Oncology 2. Pub. Med AbstractEarly Breast Cancer Trialists Collaborative Group EBCTCG. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 1. Lancet 2. 00. 5 3. Pub. Med AbstractSingletary S. Techniques in surgery therapeutic and prophylactic mastectomy. In Harris J, Lippman M, Morrow M, Osborn C, eds. Diseases of the Breast. Philadelphia, PA Lippincott Williams and Wilkins 2. Brandberg Y, Sandelin K, Erikson S, et al. Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer A prospective 1 year follow up study. Journal of Clinical Oncology  2. Pub. Med AbstractFrost MH, Hoskin TL, Hartmann LC, et al. Contralateral prophylactic mastectomy Long term consistency of satisfaction and adverse effects and the significance of informed decision making, quality of life, and personality traits. Annals of Surgical Oncology 2. Pub. Med AbstractRebbeck TR, Friebel T, Wagner T, et al. Effect of short term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers The PROSE Study Group. Journal of Clinical Oncology 2. Pub. Med AbstractCummings SR, Eckert S, Krueger KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women Results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA 1. 99. 9 2. Pub. Med AbstractFisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for the prevention of breast cancer Current status of the National Surgical Adjuvant Breast and Bowel Project P 1 study. Journal of the National Cancer Institute 2. Pub. Med AbstractVogel VG, Costantino JP, Wickerham DL, et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes the NSABP Study of Tamoxifen and Raloxifene STAR P2 trial. JAMA 2. 00. 6 2. Pub. Med AbstractVogel VG, Costantino JP, Wickerham DL, et al. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene STAR P 2 Trial Preventing breast cancer. Cancer Prevention Research 2. Pub. Med AbstractMoyer VA, From the U. S. Preventive Services Task Force R, Maryland. Medications for risk reduction of primary breast cancer in women U. S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine 2. First published online 2. September 2. 4, 2. Goss PE, Ingle JN, Als Martinez JE, et al. Exemestane for breast cancer prevention in postmenopausal women. New England Journal of Medicine 2. Pub. Med AbstractSaslow D, Boetes C, Burke W, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA A Cancer Journal for Clinicians 2. Pub. Med AbstractPhillips KA, Milne RL, Rookus MA, et al. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology 2. Pub. Med AbstractKhan SA. Contralateral prophylactic mastectomy What do we know and what do our patients know Journal of Clinical Oncology 2.